Filing Flows

Filing Flows › TransMedics Group (TMDX) › Next earnings date

TransMedics Group (TMDX) earnings: beat the estimate

TransMedics Group (TMDX) reported on Nov 5, 2026 and beat the EPS estimate: $0.51 against $0.29 (+73.8%). Revenue was $203M for Q3 2026, +41% year over year. It beat the EPS estimate in 60% of the quarters on record.

Last result+73.8% vs estimate
Beat rate60%

The last report

TransMedics Group reported revenue of $203M for the third quarter 2026 (+41% Y/Y), net earnings $17.1M: Product $113M, Service $89.6M. How it makes money → · Every quarter →

TransMedics Group: EPS against the estimate, last 5 reportsTransMedics Group: EPS against the estimate, last 5 reportsEstimateReported$0.36$0.66Oct 25$0.37$0.53Feb 26$0.61$0.30May 26$0.48$0.44Aug 26$0.29$0.51Nov 26
Latest (Nov 26): Estimate $0.29, Reported $0.51.
TMDX: the stock's move on each reportTMDX: the stock's move on each reportAug 4, 2026-6.2%May 5, 2026-24.9%Feb 24, 2026-2.1%Oct 29, 2025+4.7%

TransMedics Group's latest quarter

TransMedics Group, Q3 2026: revenue $203M (+41% year over year), operating margin 13.9%, net earnings $17.1M, operating cash flow $36.0M. The chart follows the revenue to costs, profit and cash.

Questions

Did TransMedics Group beat earnings?

TransMedics Group (TMDX) reported on Nov 5, 2026 and beat the EPS estimate: $0.51 against $0.29 (+73.8%).

When does TMDX report earnings?

The next date is not set yet.

Does TransMedics Group usually beat earnings?

It beat the consensus EPS estimate in 60% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.